Chemical pathology of acute demyelinating lesions and its correlation with disability

Annals of Neurology

Volumn 38, Issue 6, 1995, Pages 901-909

  De Stefano, Nicola ^a   Matthews, Paul M ^a,b   Antel, Jack P ^a   Preul, Mark ^a   Francis, Gordon ^a   Arnold, Douglas L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; DEXAMETHASONE; GADOLINIUM; INOSITOL; LACTIC ACID; METHYLPREDNISOLONE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATING DISEASE; DISABILITY; DISEASE COURSE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MALE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; ASPARTIC ACID; BRAIN CHEMISTRY; CHOLINE; DEMYELINATING DISEASES; DISABILITY EVALUATION; FEMALE; HUMANS; INOSITOL; LACTATES; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 0029609682     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410380610     Document Type: Article

References (37)

1. The UBC MS/MRI Study Group, The IFNB Multiple Sclerosis Study Group. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double‐blind, placebocontrolled trial
2. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation
3. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis
4. Serial gadoliniumenhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: implications for clinical trials and natural history
5. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis
6. Magnetic resonance in monitoring the treatment of multiple sclerosis
7. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
8. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques
9. Volume selection using gradients and selective pulses
10. Experimental approaches to image localized human 31P NMR spectroscopy
11. 1H NMR spectroscopic imaging
12. Data shift accumulation and alternate delay accumulation techniques for overcoming dynamic range problems
13. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis
14. Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis
15. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
16. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis
17. Rachelle Fishman‐Matthew Moore Lecture. The pathological and clinical dynamics of multiple sclerosis
18. Correlations between changes in disability and T2‐weighted brain MRI activity in multiple sclerosis: a follow‐up study
19. Longitudinal MRI in multiple sclerosis: correlation betwen disability and lesion burden
20. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis; assessment of the load of disease
21. Longitudinal, short echo time proton spectroscopic imagingof MS
22. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo
23. Axonal dystrophy as a consequence of long‐term demyelination
24. Distribution of sodium channels in chronically demyelinated spinal cord axons: immunoultrastructural localization and electrophysiological observations
25. Increase of sodium channels in demyelinated lesions of multiple sclerosis
26. Felton WL 3d. Remyelination in the human central nervous system (see comments)
27. Biochemical changes within a multiple sclerosis plaque in vivo
28. 1H spectroscopic imaging
29. Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema
30. High resolution proton NMR spectroscopy of multiple sclerosis lesions
31. Cellular and subcellular compartmentation of creatine kinase in brain
32. Detection of myelin breakdown products by proton magnetic resonance spectroscopy
33. Magnetic resonance spectroscopy of multiple sclerosis: in‐vivo detection of myelin breakdown products
34. Multiple sclerosis. Pathology of recurrent lesions